Sponsor Pipeline

Vor Biopharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease		 Trial sites expanded: 28 -> 38 locations
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06456580 A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) Generalized Myasthenia Gravis Recruiting
NCT07404865 Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease Primary Sjogren's Disease Recruiting
Disease Areas
Myasthenia Gravis (1)
Get alerts when Vor Biopharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free